CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 157 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,329,000 | -98.4% | 1,117 | -97.6% | 0.00% | – |
| Q2 2022 | $83,808,000 | +419.8% | 46,560 | +483.3% | 0.00% | – |
| Q1 2022 | $16,124,000 | -73.0% | 7,982 | -63.7% | 0.00% | – |
| Q4 2021 | $59,609,000 | -32.2% | 21,996 | +11.6% | 0.00% | – |
| Q3 2021 | $87,902,000 | +322.6% | 19,709 | +449.6% | 0.00% | – |
| Q2 2021 | $20,799,000 | -70.7% | 3,586 | -64.6% | 0.00% | – |
| Q1 2021 | $71,077,000 | -64.9% | 10,125 | -76.0% | 0.00% | – |
| Q4 2020 | $202,272,000 | +15.6% | 42,140 | +40.4% | 0.00% | – |
| Q3 2020 | $174,970,000 | -90.8% | 30,012 | -89.4% | 0.00% | -100.0% |
| Q2 2020 | $1,903,378,000 | +2.8% | 281,982 | -3.1% | 0.00% | -25.0% |
| Q1 2020 | $1,850,715,000 | +127.7% | 290,993 | +287.9% | 0.00% | +300.0% |
| Q4 2019 | $812,941,000 | +179.7% | 75,010 | +5.7% | 0.00% | – |
| Q3 2019 | $290,667,000 | -51.1% | 70,991 | +91.8% | 0.00% | -100.0% |
| Q2 2019 | $594,503,000 | -52.5% | 37,010 | -22.0% | 0.00% | -66.7% |
| Q1 2019 | $1,251,747,000 | +80.6% | 47,463 | +192.5% | 0.00% | +50.0% |
| Q4 2018 | $693,220,000 | -50.4% | 16,224 | -6.0% | 0.00% | 0.0% |
| Q3 2018 | $1,396,867,000 | -28.4% | 17,267 | +37.0% | 0.00% | -50.0% |
| Q2 2018 | $1,950,527,000 | -8.6% | 12,603 | -68.8% | 0.00% | 0.0% |
| Q1 2018 | $2,134,440,000 | +245.2% | 40,425 | +344.6% | 0.00% | +300.0% |
| Q4 2017 | $618,324,000 | +44.4% | 9,093 | +74.9% | 0.00% | 0.0% |
| Q3 2017 | $428,315,000 | -12.9% | 5,198 | -1.0% | 0.00% | 0.0% |
| Q2 2017 | $491,557,000 | +860.2% | 5,250 | +553.0% | 0.00% | – |
| Q1 2017 | $51,191,000 | -49.4% | 804 | -64.7% | 0.00% | – |
| Q4 2016 | $101,100,000 | +6.3% | 2,276 | -13.8% | 0.00% | – |
| Q3 2016 | $95,136,000 | +461.9% | 2,639 | +113.9% | 0.00% | – |
| Q2 2016 | $16,930,000 | -92.8% | 1,234 | -81.7% | 0.00% | -100.0% |
| Q4 2015 | $235,410,000 | -54.1% | 6,726 | +20.7% | 0.00% | 0.0% |
| Q3 2015 | $512,401,000 | +181.8% | 5,572 | +169.3% | 0.00% | 0.0% |
| Q2 2015 | $181,824,000 | +318.0% | 2,069 | +253.1% | 0.00% | – |
| Q1 2015 | $43,499,000 | -34.1% | 586 | -59.7% | 0.00% | – |
| Q3 2014 | $65,999,000 | +378.2% | 1,455 | +535.4% | 0.00% | – |
| Q4 2013 | $13,802,000 | -94.5% | 229 | -94.4% | 0.00% | – |
| Q3 2013 | $248,915,000 | -24.7% | 4,094 | -17.1% | 0.00% | – |
| Q2 2013 | $330,613,000 | – | 4,936 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |